5345-57-3

Upstream product

• 86-68-0 6-methoxyquinoline-4-carboxylic acid 
• 617-35-6 2-oxo-propionic acid ethyl ester 
• 109-87-5 Dimethoxymethane 
• 104-94-9 4-methoxy-aniline 
• 75-03-6 ethyl iodide 
• 64-17-5 ethanol 
• 857622-89-0 N-(4-methoxy-phenyl)-N-methyl-2-oxo-succinamic acid ethyl ester 
• 66695-42-9 ethyl 6-methoxy-1-methyl-2-oxo-1,2-dihydroquinoline-4-carboxylate 
• 35813-38-8 N-(4-methoxyphenyl)-N-methylacetamide 
• 5345-56-2 2-chloro-6-methoxy-quinoline-4-carboxylic acid ethyl ester 
• 858276-95-6 2-iodo-6-methoxy-quinoline-4-carboxylic acid 

Downstream Products

• 86-68-0 6-methoxyquinoline-4-carboxylic acid 
• 84-55-9 rac-6'-methoxy-1,8-seco-cinchonan-9-one 
• 92288-15-8 (6-methoxyquinolin-4-yl)methanol 
• 84-55-9 viquidil 
• 6279-51-2 6-methoxy-4-aminoquinoline 

Relevant academic research and scientific papers

COMBINATION PHARMACEUTICAL AGENTS AS RSV INHIBITORS

The present invention relates to pharmaceutical agents administered to a subject either in combination or in series for the treatment of a Respiratory Syncytial Virus (RSV) infection, wherein treatment comprises administering a compound effective to inhibit the function of the RSV and an additional compound or combinations of compounds having anti-RSV activity.

BENZODIAZEPINE DERIVATIVES AS RSV INHIBITORS

The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

4-(1-AMINO-ETHYL)-CYCLOHEXYLAMINE DERIVATIVES

The invention relates to compounds of formula (I) wherein R0 represents H or OH; R1 represents alkoxy; U and W represent N, V represents CH and R2 represents H or F, or U and V represent CH, W represents N and R2 /su

4-(1-AMINO-ETHYL)-CYCLOHEXYLAMINE DERIVATIVES

The invention relates to compounds of formula (I) wherein R0 represents H or OH; R1 represents alkoxy; U and W represent N, V represents CH and R2 represents H or F, or U and V represent CH, W represents N and R2/sup